Investigation Of The Functional Role Of Parkin And PArkin Co-Regulated Gene (PACRG) In Neurodegenerative Disease.
Funder
National Health and Medical Research Council
Funding Amount
$82,421.00
Summary
Parkinson’s disease (PD) is a chronic neurodegenerative disorder affecting greater than 1% of the population at 65 years of age. Current treatment regimes treat the motor-associated symptoms of disease - tremor and muscle rigidity. There is no cure, or effective treatment to reverse or halt disease progression. Understanding the role of dysregulated proteins in the progression of PD will identify new targets for treatment of the motor and cognitive deficits observed in PD-affected individuals.